Evidence map›Paper›PMID 35273503›Full record

ArticleFrontiers in pharmacology2022

Expression and Functions of the CB

Mélissa Simard, Volatiana Rakotoarivelo, Vincenzo Di Marzo, Nicolas Flamand

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Role of the Endocannabinoid System in Fibromyalgia.Current issues in molecular biology · 2025
    Review
  12. Utilization of Cannabidiol in Post-Organ-Transplant Care.International journal of molecular sciences · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. The Impact of the CBMolecules (Basel, Switzerland) · 2024
    Review
  19. Role of Cannabinoids in Oral Cancer.International journal of molecular sciences · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mélissa SimardCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Département of Médecine, Faculté de Médecine, Université Laval, Québec City, QC, Canada.
Volatiana RakotoariveloCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Département of Médecine, Faculté de Médecine, Université Laval, Québec City, QC, Canada.
Vincenzo Di MarzoCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Département of Médecine, Faculté de Médecine, Université Laval, Québec City, QC, Canada.
Nicolas FlamandCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Département of Médecine, Faculté de Médecine, Université Laval, Québec City, QC, Canada.
Institut Universitaire de Cardiologie et de Pneumologie de Québec · CAUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cannabinoid CB

Indexed as

allergyasthmaCB2 receptoreosinophilinflammationlymphocytemonocyteneutrophil

Identifiers

PMID35273503
PMCPMC8902156
OpenAlexW4212862906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.